Lytix Biopharma AS is a biotechnology company that specializes in research and development within immuno-oncology. The company has a strong focus on clinical programs and collaborates with various players in the field to promote its projects. Lytix Biopharma has an experienced team of specialists who lead the work in developing innovative treatment methods.
The company actively participates in financial and scientific events, which helps to strengthen the network and visibility in the industry. Lytix Biopharma also offers information to investors and shareholders, and has published scientific articles and posters that are available to interested parties. Presentations of clinical results are part of the company's communication to share progress and findings with the wider community.
